Fluconazole Dosing for Candida Wound Infection in Hemodialysis Patients

Introduction to Treatment

The American College of Physicians and the Infectious Diseases Society of America recommend initiating therapy with an 800 mg (12 mg/kg) loading dose on Day 1, followed by the maintenance regimen, to ensure rapid achievement of therapeutic concentrations in hemodialysis patients with Candida wound infections 2, 3

The Infectious Diseases Society of America suggests administering 400 mg (6 mg/kg) after each hemodialysis session, typically 3 times weekly for standard intermittent HD, to maintain therapeutic levels in hemodialysis patients with Candida wound infections 1

The Clinical Infectious Diseases guidelines recommend continuing therapy for at least 2 weeks after clinical resolution of the wound infection, and for more severe or deep tissue involvement, extend treatment duration based on clinical response and imaging if applicable, to prevent premature discontinuation and relapse risk 2, 3

The Infectious Diseases Society of America advises ensuring adequate source control, such as debridement of necrotic tissue and drainage of any collections, which is essential for treatment success in hemodialysis patients with Candida wound infections 2
The Clinical Infectious Diseases guidelines suggest obtaining susceptibility testing to confirm fluconazole susceptibility, as resistance patterns vary, and if the isolate is C. glabrata or C. krusei, fluconazole may not be appropriate—consider amphotericin B deoxycholate 0.3-0.6 mg/kg daily or an echinocandin instead 1, 2

The Praxis Medical Insights guidelines warn against underdosing, as the 400 mg post-dialysis dose is necessary for serious infections, and lower doses (200 mg) are only appropriate for less severe infections like candiduria, and assuming all Candida species are fluconazole-susceptible, as C. krusei is intrinsically resistant and C. glabrata often has reduced susceptibility 1